טוען...
Pharmacokinetics and pharmacodynamics of immediate release vs. extended release guanfacine in adult daily smokers
BACKGROUND: Guanfacine is FDA-approved for hypertension and ADHD and has been used off-label for migraine prophylaxis, heroin withdrawal, and more recently, smoking cessation. Prior studies have shown positive effects of 3mg/day immediate-release (IR) guanfacine on smoking outcomes but the dose equi...
שמור ב:
| הוצא לאור ב: | J Clin Psychopharmacol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6391212/ https://ncbi.nlm.nih.gov/pubmed/30707118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000001004 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|